113 related articles for article (PubMed ID: 12077687)
1. Influence of ACE inhibition on myocardial damage, the Kallikrein-Kinin system and hemostasis during cardiopulmonary bypass surgery.
Walter T; Helber U; Bail D; Heller W; Hoffmeister HM
Thorac Cardiovasc Surg; 2002 Jun; 50(3):150-4. PubMed ID: 12077687
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
[TBL] [Abstract][Full Text] [Related]
3. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
4. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-kinin system activation and its interactions with other plasma haemostatic components in the coronary artery disease.
Czokało-Plichta M; Skibinska E; Kosiorek P; Musiał WJ
Rocz Akad Med Bialymst; 2001; 46():209-24. PubMed ID: 11780565
[TBL] [Abstract][Full Text] [Related]
6. Absence of myocardial release of troponin T after coronary bypass surgery on a beating heart.
Takriti SA; Hindaoui R; Jouma M; Bitar MS
Int J Surg Investig; 1999; 1(4):271-6. PubMed ID: 12774448
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin preconditioning in coronary artery bypass grafting.
Wei M; Wang X; Kuukasjärvi P; Laurikka J; Rinne T; Honkonen EL; Tarkka M
Ann Thorac Surg; 2004 Aug; 78(2):492-7. PubMed ID: 15276504
[TBL] [Abstract][Full Text] [Related]
8. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery.
Yamamoto S; Yamada T; Kotake Y; Takeda J
J Cardiothorac Vasc Anesth; 2008 Aug; 22(4):548-53. PubMed ID: 18662629
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
12. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine may protect the myocardium during cardiac surgery.
Iskesen I; Kurdal AT; Eserdag M; Cerrahoglu M; Sirin BH
Heart Surg Forum; 2009 Jun; 12(3):E175-9. PubMed ID: 19546072
[TBL] [Abstract][Full Text] [Related]
14. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
16. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
[TBL] [Abstract][Full Text] [Related]
17. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
19. [Effect of captopril on human myocardial ACE-inhibition: neurohumoral variations during coronary sinus cardioplegia. Cardioprotective effect during aortocoronary bypass].
Di Pasquale P; Paterna S; Valenza M; Valdes L; Albano V; Trombino G; Vitrano G; Licata G; Albiero R
Cardiologia; 1992 Nov; 37(11):805-8. PubMed ID: 1338525
[TBL] [Abstract][Full Text] [Related]
20. Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
Kirali K; Mansuroğlu D; Kayalar N; Güzelmeriç F; Alp M; Yakut C
Heart Surg Forum; 2003; 6(3):143-8. PubMed ID: 12821428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
